TY - JOUR
T1 - がん免疫療法のトランスレーショナルリサーチ
AU - Nishi, Tatsuya
AU - Togashi, Yosuke
N1 - Publisher Copyright:
© 2022 The Japan Lung Cancer Society.
PY - 2022
Y1 - 2022
N2 - Although a great deal of research on cancer immunotherapy has been conducted using mice, there are many differences between humans and mice, which is associated with some limitations. Therefore, the analysis of human clinical specimens is important for elucidating the essence of cancer immunology. Recently, advances in technology have made it possible to perform comprehensive gene analyses of various clinical specimens. While such analyses are often performed in bulk, we believe that it is important to analyze clinical specimens at the single-cell level in order to understand the role of each cell, including various immune cells, in detail. Various novel findings have been obtained from such analyses.
AB - Although a great deal of research on cancer immunotherapy has been conducted using mice, there are many differences between humans and mice, which is associated with some limitations. Therefore, the analysis of human clinical specimens is important for elucidating the essence of cancer immunology. Recently, advances in technology have made it possible to perform comprehensive gene analyses of various clinical specimens. While such analyses are often performed in bulk, we believe that it is important to analyze clinical specimens at the single-cell level in order to understand the role of each cell, including various immune cells, in detail. Various novel findings have been obtained from such analyses.
KW - Biomarker
KW - CD8+ T cells
KW - Neoantigen
KW - Translational research
KW - Tumor immunity
UR - http://www.scopus.com/inward/record.url?scp=85142068534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142068534&partnerID=8YFLogxK
U2 - 10.2482/haigan.62.363
DO - 10.2482/haigan.62.363
M3 - Review article
AN - SCOPUS:85142068534
SN - 0386-9628
VL - 62
SP - 363
EP - 370
JO - Japanese Journal of Lung Cancer
JF - Japanese Journal of Lung Cancer
IS - 5
ER -